<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="595cc3d5-1306-4828-aefa-5595219ffd62"><labelDrug name="Brevibloc"><Normalization><mmtx cui="C0591189" preferredWord="Brevibloc" semType="phsu, orch"/></Normalization></labelDrug><generic name="Esmolol Hydrochloride"/><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.2" text="&lt;main&gt;BREVIBLOC injection is a beta adrenergic blocker indicated for the short-term treatment of:" type="negative"><entity charOffset="31:54" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.2.e.0" text="beta adrenergic blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C3536830" phraseText="a beta adrenergic blocker" preferredWord="beta-Adrenergic Blocker [EPC]" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="6:25" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.2.e.1" text="brevibloc injection" type="Biomedical_Entity"><Normalization><mmtx cui="C0305488" phraseText="&gt;BREVIBLOC injection" preferredWord="esmolol Injectable Solution [Brevibloc]" semType="clnd"/><RxNorm RxCui="151448"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.2.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.2.e.0"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.5" text="BREVIBLOC (Esmolol Hydrochloride) is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. " type="negative"><entity charOffset="11:32" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.5.e.0" text="esmolol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0700606" phraseText="(Esmolol Hydrochloride" preferredWord="Esmolol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="49737"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.5.e.1" text="brevibloc" type="Biomedical_Entity"><Normalization><mmtx cui="C0591189" phraseText="BREVIBLOC" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.5.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.5.e.0"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.8" text="BREVIBLOC (Esmolol Hydrochloride) is indicated for the short-term treatment of tachycardia and hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anesthesia and in the postoperative period, when in the physician s judgment such specific intervention is considered indicated." type="negative"><entity charOffset="11:32" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.8.e.0" text="esmolol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0700606" phraseText="(Esmolol Hydrochloride" preferredWord="Esmolol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="49737"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.8.e.1" text="brevibloc" type="Biomedical_Entity"><Normalization><mmtx cui="C0591189" phraseText="BREVIBLOC" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="195:205" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.8.e.2" text="anesthesia" type="Biomedical_Entity"><Normalization><mmtx cui="C0002932" phraseText="from anesthesia" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="239756"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.8.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.8.e.0"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.8.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.8.e.2"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.8.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.8.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35" lineNumber="56" text="When transitioning from BREVIBLOC to alternative drugs, the physician should carefully consider the labeling instructions of the alternative drug selected and reduce the dosage of BREVIBLOC as follows:" type="regular"><entity charOffset="24:33" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.0" text="BREVIBLOC" type="Drug"><Normalization><mmtx cui="C0591189" phraseText="transitioning from BREVIBLOC" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="87:121" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.1" text="consider the labeling instructions" type="Caution_Interaction"/><entity charOffset="159:176" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.3" text="reduce the dosage" type="Caution_Interaction"/><entity charOffset="180:189" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.5" text="BREVIBLOC" type="Drug"><Normalization><mmtx cui="C0591189" phraseText="the dosage of BREVIBLOC" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="129:145" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.6" text="alternative drug" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="the labeling instructions of the alternative drug" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C1254351" phraseText="the labeling instructions of the alternative drug" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="691608"/></Normalization></entity><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.ddi.2"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.6" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.1" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.6" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.5" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.35.e.3" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.36" lineNumber="59" text="&lt;item&gt;Thirty minutes following the first dose of the alternative drug, reduce the BREVIBLOC infusion rate by one-half (50%)." type="regular"><entity charOffset="71:81|92:105" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.36.e.0" text="reduce the infusion rate" type="Caution_Interaction"/><entity charOffset="82:91" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.36.e.2" text="BREVIBLOC" type="Drug"><Normalization><mmtx cui="C0591189" phraseText="the BREVIBLOC infusion rate by one-half" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="53:69" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.36.e.3" text="alternative drug" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="the first dose of the alternative drug," preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C1254351" phraseText="the first dose of the alternative drug," preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="691608"/></Normalization></entity><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.36.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.36.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.36.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.36.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.36.e.3" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.36.e.2" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.36.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37" lineNumber="61" text="&lt;item&gt;After administration of the second dose of the alternative drug, monitor the patient's response and if satisfactory control is maintained for the first hour, discontinue the BREVIBLOC infusion." type="regular"><entity charOffset="71:78" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="53:69" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.e.2" text="alternative drug" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="of the alternative drug," preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C1254351" phraseText="of the alternative drug," preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="691608"/></Normalization></entity><entity charOffset="180:198" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.e.3" text="BREVIBLOC infusion" type="Drug"><Normalization><mmtx cui="C0591189" phraseText="the BREVIBLOC infusion." preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="164:175" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.e.4" text="discontinue" type="Caution_Interaction"/><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.ddi.2"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.e.3" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.37.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39" lineNumber="64" text="BREVIBLOC is not compatible with Sodium Bicarbonate (5%) solution (limited stability) or furosemide (precipitation)." type="regular"><entity charOffset="89:99" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.0" text="furosemide" type="Drug"><Normalization><mmtx cui="C0016860" phraseText="furosemide" preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.1" text="BREVIBLOC" type="Drug"><Normalization><mmtx cui="C0591189" phraseText="BREVIBLOC" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="13:27" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.2" text="not compatible" type="Caution_Interaction"/><entity charOffset="33:65" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.4" text="Sodium Bicarbonate (5%) solution" type="Substance"><Normalization><mmtx cui="C0074722" phraseText="not compatible with Sodium Bicarbonate" preferredWord="Sodium Bicarbonate" semType="phsu, orch"/><RxNorm RxCui="9853"/></Normalization></entity><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.2"><relations><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.0" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.2" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.4" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.2" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.4" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.39.e.0"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.45" text="&lt;main&gt;BREVIBLOC was tested for compatibility with ten commonly used intravenous fluids at a final concentration of 10 mg esmolol hydrochloride per mL. " type="negative"><entity charOffset="121:142" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.45.e.0" text="esmolol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0700606" phraseText="intravenous fluids at a final concentration of 10 mg esmolol hydrochloride" preferredWord="Esmolol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="49737"/></Normalization></entity><entity charOffset="6:15" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.45.e.1" text="brevibloc" type="Biomedical_Entity"><Normalization><mmtx cui="C0591189" phraseText="&gt;BREVIBLOC" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.45.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.45.e.0"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.48" text="&lt;item&gt;Dextrose (5%) in Lactated Ringer s Injection" type="negative"><entity charOffset="6:14" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.48.e.0" text="dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="&gt;Dextrose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><entity charOffset="23:50" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.48.e.1" text="lactated ringer injection" type="Biomedical_Entity"><Normalization><mmtx cui="C0140600" phraseText="in Lactated Ringer s Injection" preferredWord="Calcium Chloride 0.0014 MEQ/ML / Potassium Chloride 0.004 MEQ/ML / Sodium Chloride 0.103 MEQ/ML / Sodium Lactate 0.028 MEQ/ML Injectable Solution" semType="clnd"/><RxNorm RxCui="114202"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.48.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.48.e.1"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.49" text="&lt;item&gt;Dextrose (5%) in Ringer s Injection" type="negative"><entity charOffset="23:29" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.49.e.0" text="ringer" type="Biomedical_Entity"><Normalization><mmtx cui="C1875730" phraseText="in Ringer s Injection" preferredWord="RINGER'S" semType="phsu, orch"/><RxNorm RxCui="35629"/></Normalization></entity><entity charOffset="6:14" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.49.e.1" text="dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="&gt;Dextrose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.49.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.49.e.0"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.50" text="&lt;item&gt;Dextrose (5%) and Sodium Chloride (0.45%) Injection, USP" type="negative"><entity charOffset="24:39" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.50.e.0" text="sodium chloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0037494" phraseText="Sodium Chloride" preferredWord="Sodium Chloride" semType="bacs, inch, phsu"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="6:14" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.50.e.1" text="dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="&gt;Dextrose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.50.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.50.e.0"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.51" text="&lt;item&gt;Dextrose (5%) and Sodium Chloride (0.9%) Injection, USP" type="negative"><entity charOffset="24:39" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.51.e.0" text="sodium chloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0037494" phraseText="Sodium Chloride" preferredWord="Sodium Chloride" semType="bacs, inch, phsu"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="6:14" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.51.e.1" text="dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="&gt;Dextrose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.51.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.51.e.0"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.53" text="&lt;item&gt;Potassium Chloride (40 mEq/liter) in Dextrose (5%) Injection, USP" type="negative"><entity charOffset="43:51" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.53.e.0" text="dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="in Dextrose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><entity charOffset="6:24" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.53.e.1" text="potassium chloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0032825" phraseText="&gt;Potassium Chloride" preferredWord="Potassium Chloride" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.53.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.53.e.0"/></sentence><sentence biomedicalEntities="0" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.58" lineNumber="103" text="&lt;main&gt;BREVIBLOC (Esmolol Hydrochloride) is contraindicated in patients with:" type="regular"><entity charOffset="43:58" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.58.e.0" text="contraindicated" type="Caution_Interaction"/><entity charOffset="43:58" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.58.e.2" text="contraindicated" type="SPAN"/><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.58.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.58.e.0"><relations><relation type="hasSeverity"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.58.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.0"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="5" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64" lineNumber="115" text="&lt;item&gt;IV administration of cardiodepressant calcium-channel antagonists (e.g., verapamil) and BREVIBLOC in close proximity (i.e., while cardiac effects from the other are still present), fatal cardiac arrests have occurred in patients receiving BREVIBLOC and intravenous verapamil." type="regular"><entity charOffset="6:71" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.0" text="IV administration of cardiodepressant calcium-channel antagonists" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="&gt;IV administration of cardiodepressant calcium-channel antagonists" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="79:88" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.1" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="259:280" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.3" text="intravenous verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="intravenous verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="94:103" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.4" text="BREVIBLOC" type="Drug"><Normalization><mmtx cui="C0591189" phraseText="BREVIBLOC in close proximity" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="245:254" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.5" text="BREVIBLOC" type="Drug"><Normalization><mmtx cui="C0591189" phraseText="BREVIBLOC" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="193:208" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.6" text="cardiac arrests" type="Specific_Interaction"><Normalization><mmtx cui="C0018790" phraseText="fatal cardiac arrests" preferredWord="Cardiac Arrest" semType="dsyn"/></Normalization></entity><entity charOffset="187:192" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.8" text="fatal" type="SPAN"/><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.1" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.0"/><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.6"><relations><relation type="hasSeverity"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.8"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.5" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.3" severity="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.8" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.6" type="Specific_Interaction"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.66" text="&lt;item&gt;Hypersensitivity reactions, including anaphylaxis, to esmolol or any of the inactive ingredients of the product (cross-sensitivity between beta blockers is possible)." type="negative"><entity charOffset="145:158" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.66.e.0" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="(cross-sensitivity between beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="60:67" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.66.e.1" text="esmolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0116569" phraseText="to esmolol" preferredWord="esmolol" semType="phsu, orch"/><RxNorm RxCui="49737"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.66.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.66.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.71" lineNumber="131" text="&lt;item&gt;Diabetes mellitus: Increases the effect of hypoglycemic agents and masks hypoglycemic tachycardia (5.6)" type="irregular"><entity charOffset="25:45" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.71.e.0" text="Increases the effect" type="Increase_Interaction"/><entity charOffset="49:68" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.71.e.2" text="hypoglycemic agents" type="Drug_Class"><Normalization><mmtx cui="C0020616" phraseText="the effect of hypoglycemic agents" preferredWord="Hypoglycemic Agents" semType="phsu"/><RxNorm RxCui="5604"/></Normalization></entity><entity charOffset="6:23" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.71.e.3" text="Diabetes mellitus" type="SPAN"><Normalization><mmtx cui="C0011849" phraseText="&gt;Diabetes mellitus" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.71.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.71.e.0"><relations><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.71.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.71.e.3"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64" text="&lt;item&gt;IV administration of cardiodepressant calcium-channel antagonists (e.g., verapamil) and BREVIBLOC in close proximity (i.e., while cardiac effects from the other are still present), fatal cardiac arrests have occurred in patients receiving BREVIBLOC and intravenous verapamil."><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.64.e.5"/></ellipsisSentence><middleSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.65" text="&lt;item&gt;Pulmonary hypertension: May precipitate cardiorespiratory compromise."/><middleSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.66" text="&lt;item&gt;Hypersensitivity reactions, including anaphylaxis, to esmolol or any of the inactive ingredients of the product (cross-sensitivity between beta blockers is possible)."/><middleSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.67" text="WARNINGS AND PRECAUTIONS SECTION"/><middleSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.68" text="&lt;item&gt;Risk of hypotension, bradycardia, and cardiac failure: Monitor for signs and symptoms of cardiovascular adverse effects. "/><middleSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.69" text="Reduce or discontinue use (5.1, 5.2, 5.3, 5.10)"/><middleSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.70" text="&lt;item&gt;Risk of exacerbating reactive airway disease (5.5)"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.85" text="Beta blockers, like BREVIBLOC injection, can cause depression of myocardial contractility and may precipitate heart failure and cardiogenic shock. " type="negative"><entity charOffset="0:13" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.85.e.0" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="Beta blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="20:39" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.85.e.1" text="brevibloc injection" type="Biomedical_Entity"><Normalization><mmtx cui="C0305488" phraseText="like BREVIBLOC injection," preferredWord="esmolol Injectable Solution [Brevibloc]" semType="clnd"/><RxNorm RxCui="151448"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.85.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.85.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91" lineNumber="144" text="In patients with hypoglycemia, or diabetic patients (especially those with labile diabetes) who are receiving insulin or other hypoglycemic agents, beta blockers may mask tachycardia occurring with hypoglycemia, but other manifestations such as dizziness and sweating may not be masked." type="regular"><entity charOffset="34:51" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.0" text="diabetic patients" type="SPAN"/><entity charOffset="110:117" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.1" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="receiving insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="receiving insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="receiving insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="127:146" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.2" text="hypoglycemic agents" type="Drug_Class"><Normalization><mmtx cui="C0020616" phraseText="other hypoglycemic agents," preferredWord="Hypoglycemic Agents" semType="phsu"/><RxNorm RxCui="5604"/></Normalization></entity><entity charOffset="148:161" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.3" text="beta blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="171:182" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.4" text="tachycardia" type="Specific_Interaction"/><entity charOffset="198:210" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.6" text="hypoglycemia" type="Specific_Interaction"><Normalization><mmtx cui="C0020615" phraseText="occurring with hypoglycemia," preferredWord="Hypoglycemia" semType="dsyn"/></Normalization></entity><entity charOffset="245:254" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.8" text="dizziness" type="Specific_Interaction"><Normalization><mmtx cui="C0012833" phraseText="other manifestations such as dizziness" preferredWord="Dizziness" semType="sosy"/><mmtx cui="C0042571" phraseText="other manifestations such as dizziness" preferredWord="Vertigo" semType="sosy"/></Normalization></entity><entity charOffset="259:267" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.10" text="sweating" type="Specific_Interaction"/><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.4"><relations><relation type="hasContext"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.ddi.2"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.6"><relations><relation type="hasContext"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.ddi.3"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.8"><relations><relation type="hasContext"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.ddi.4"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.10"><relations><relation type="hasContext"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.0" ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.3" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.4" type="Specific_Interaction"/><pair context="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.0" ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.3" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.4" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.2"/><pair context="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.0" ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.3" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.6" type="Specific_Interaction"/><pair context="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.0" ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.3" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.6" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.91.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.92" lineNumber="145" text="Concomitant use of beta blockers and antidiabetic agents can enhance the effect of antidiabetic agents (blood glucose lowering)." type="regular"><entity charOffset="19:32" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.92.e.0" text="beta blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="Concomitant use of beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="61:79" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.92.e.1" text="enhance the effect" type="Increase_Interaction"/><entity charOffset="83:102" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.92.e.3" text="antidiabetic agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="the effect of antidiabetic agents" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.92.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.92.e.1"><relations><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.92.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.92.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.92.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.92.e.3" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.92.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.97" text="Beta blockers may exacerbate anginal attacks in patients with Prinzmetal s angina because of unopposed alpha receptor mediated coronary artery vasoconstriction. " type="negative"><entity charOffset="0:13" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.97.e.0" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="Beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="118:126" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.97.e.1" text="mediated" type="Biomedical_Entity"><Normalization><mmtx cui="C0127400" phraseText="mediated" preferredWord="Mediator brand of benfluorex hydrochloride" semType="phsu, orch"/><RxNorm RxCui="985488"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.97.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.97.e.1"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.99" text="If BREVIBLOC is used in the setting of pheochromocytoma, give it in combination with an alpha-blocker, and only after the alpha-blocker has been initiated. " type="negative"><entity charOffset="3:12" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.99.e.0" text="brevibloc" type="Biomedical_Entity"><Normalization><mmtx cui="C0591189" phraseText="BREVIBLOC" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="122:135" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.99.e.1" text="alpha-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="only after the alpha-blocker" preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="1023426"/></Normalization></entity><entity charOffset="88:101" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.99.e.2" text="alpha-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="with an alpha-blocker," preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="1023426"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.99.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.99.e.1"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.99.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.99.e.2"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.100" text="Administration of beta-blockers alone in the setting of pheochromocytoma has been associated with a paradoxical increase in blood pressure from the attenuation of beta-mediated vasodilation in skeletal muscle." type="negative"><entity charOffset="18:31" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.100.e.0" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="Administration of beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="168:176" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.100.e.1" text="mediated" type="Biomedical_Entity"><Normalization><mmtx cui="C0127400" phraseText="of beta-mediated vasodilation" preferredWord="Mediator brand of benfluorex hydrochloride" semType="phsu, orch"/><RxNorm RxCui="985488"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.100.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.100.e.1"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.106" text="Beta blockers, including BREVIBLOC, have been associated with increases in serum potassium levels and hyperkalemia. " type="negative"><entity charOffset="81:90" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.106.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="in serum potassium levels" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="25:34" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.106.e.1" text="brevibloc" type="Biomedical_Entity"><Normalization><mmtx cui="C0591189" phraseText="BREVIBLOC," preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="0:13" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.106.e.2" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="Beta blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.106.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.106.e.0"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.106.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.106.e.0"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.106.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.106.e.1"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.109" text="Monitor serum electrolytes during therapy with BREVIBLOC." type="negative"><entity charOffset="14:26" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.109.e.0" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="Monitor serum electrolytes during therapy" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="47:56" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.109.e.1" text="brevibloc" type="Biomedical_Entity"><Normalization><mmtx cui="C0591189" phraseText="with BREVIBLOC." preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.109.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.109.e.1"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.110" text="Beta blockers, including BREVIBLOC, have been reported to cause hyperkalemic renal tubular acidosis. " type="negative"><entity charOffset="25:34" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.110.e.0" text="brevibloc" type="Biomedical_Entity"><Normalization><mmtx cui="C0591189" phraseText="BREVIBLOC," preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="0:13" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.110.e.1" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="Beta blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.110.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.110.e.0"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.114" text="When using beta blockers, patients at risk of anaphylactic reactions may be more reactive to allergen exposure (accidental, diagnostic, or therapeutic)." type="negative"><entity charOffset="93:101" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.114.e.0" text="allergen" type="Biomedical_Entity"><Normalization><mmtx cui="C3274161" phraseText="more reactive to allergen exposure" preferredWord="Allergen (brand of diphenylpyraline)" semType="phsu, orch"/><RxNorm RxCui="1297244"/></Normalization></entity><entity charOffset="11:24" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.114.e.1" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.114.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.114.e.0"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.115" text="Patients using beta blockers may be unresponsive to the usual doses of epinephrine used to treat anaphylactic or anaphylactoid reactions see Drug Interactions (7)." type="negative"><entity charOffset="71:82" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.115.e.0" text="epinephrine" type="Biomedical_Entity"><Normalization><mmtx cui="C0014563" phraseText="unresponsive to the usual doses of epinephrine" preferredWord="Epinephrine" semType="phsu, orch, horm, nsba"/><RxNorm RxCui="362"/></Normalization></entity><entity charOffset="15:28" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.115.e.1" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.115.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.115.e.0"/></sentence><sentence biomedicalEntities="6" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117" lineNumber="163" text="&lt;main&gt;Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure, reduce myocardial contractility, or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC's effects on blood pressure, contractility, and impulse propagation. " type="regular"><entity charOffset="25:44" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.0" text="BREVIBLOC injection" type="Drug"><Normalization><mmtx cui="C0305488" phraseText="&gt;Concomitant use of BREVIBLOC injection" preferredWord="esmolol Injectable Solution [Brevibloc]" semType="clnd"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="56:91" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.1" text="drugs that can lower blood pressure" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="with other drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="56:70|93:124" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.2" text="drugs that can reduce myocardial contractility" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="with other drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="56:70|129:163" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.3" text="drugs that can interfere with sinus node function" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="with other drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="56:70|129:143|167:215" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.4" text="drugs that can interfere with electrical impulse propagation in the myocardium" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="with other drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="220:230|243:268" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.5" text="exaggerate effects on blood pressure" type="Specific_Interaction"/><entity charOffset="220:230|243:253|270:283" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.7" text="exaggerate effects on contractility" type="Specific_Interaction"/><entity charOffset="220:230|243:253|289:308" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.9" text="exaggerate effects on impulse propagation" type="Specific_Interaction"/><entity charOffset="231:240" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.11" text="BREVIBLOC" type="Drug"><Normalization><mmtx cui="C0591189" phraseText="BREVIBLOC's effects on blood pressure," preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.ddi.2"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.ddi.3"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.4" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.5" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.3" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.5" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.2" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.5" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.1" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.5" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.3" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.4"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.4"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.4"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.3"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.3"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.2"/></sentence><sentence biomedicalEntities="0" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118" lineNumber="163" text="Severe interactions with such drugs can result in, for example, severe hypotension, cardiac failure, severe bradycardia, sinus pause, sinoatrial block, atrioventricular block, and/or cardiac arrest. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117" Text="&lt;main&gt;Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure, reduce myocardial contractility, or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC's effects on blood pressure, contractility, and impulse propagation. "/><anaphoraEntity charOffset="25:35" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.14" text="such drugs" type="Expression"/><antecedentEntity charOffset="56:91" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.1" text="drugs that can lower blood pressure" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117" Text="&lt;main&gt;Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure, reduce myocardial contractility, or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC's effects on blood pressure, contractility, and impulse propagation. "/><anaphoraEntity charOffset="25:35" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.14" text="such drugs" type="Expression"/><antecedentEntity charOffset="56:124" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.2" text="drugs that can reduce myocardial contractility" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117" Text="&lt;main&gt;Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure, reduce myocardial contractility, or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC's effects on blood pressure, contractility, and impulse propagation. "/><anaphoraEntity charOffset="25:35" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.14" text="such drugs" type="Expression"/><antecedentEntity charOffset="56:163" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.3" text="drugs that can interfere with sinus node function" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117" Text="&lt;main&gt;Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure, reduce myocardial contractility, or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC's effects on blood pressure, contractility, and impulse propagation. "/><anaphoraEntity charOffset="25:35" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.14" text="such drugs" type="Expression"/><antecedentEntity charOffset="56:215" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.4" text="drugs that can interfere with electrical impulse propagation in the myocardium" type="Drug_Class"/></anaphoraRelation><entity charOffset="64:82" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.0" text="severe hypotension" type="Specific_Interaction"/><entity charOffset="84:99" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.2" text="cardiac failure" type="Specific_Interaction"><Normalization><mmtx cui="C0018801" phraseText="cardiac failure," preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="cardiac failure," preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><entity charOffset="101:119" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.4" text="severe bradycardia" type="Specific_Interaction"/><entity charOffset="121:132" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.6" text="sinus pause" type="Specific_Interaction"/><entity charOffset="134:150" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.8" text="sinoatrial block" type="Specific_Interaction"><Normalization><mmtx cui="C0037188" phraseText="sinoatrial block," preferredWord="Sinoatrial Block" semType="dsyn"/></Normalization></entity><entity charOffset="152:174" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.10" text="atrioventricular block" type="Specific_Interaction"><Normalization><mmtx cui="C0004245" phraseText="atrioventricular block," preferredWord="Atrioventricular Block" semType="dsyn"/></Normalization></entity><entity charOffset="183:197" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.12" text="cardiac arrest" type="Specific_Interaction"><Normalization><mmtx cui="C0018790" phraseText="cardiac arrest." preferredWord="Cardiac Arrest" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117" text="&lt;main&gt;Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure, reduce myocardial contractility, or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC's effects on blood pressure, contractility, and impulse propagation. "><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.11"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.14"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.ddi.2"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.2"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117" text="&lt;main&gt;Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure, reduce myocardial contractility, or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC's effects on blood pressure, contractility, and impulse propagation. "><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.11"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.14"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.ddi.3"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.4"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117" text="&lt;main&gt;Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure, reduce myocardial contractility, or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC's effects on blood pressure, contractility, and impulse propagation. "><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.11"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.14"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.ddi.4"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.6"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117" text="&lt;main&gt;Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure, reduce myocardial contractility, or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC's effects on blood pressure, contractility, and impulse propagation. "><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.11"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.14"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.ddi.5"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.8"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117" text="&lt;main&gt;Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure, reduce myocardial contractility, or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC's effects on blood pressure, contractility, and impulse propagation. "><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.11"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.14"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.ddi.6"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.10"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117" text="&lt;main&gt;Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure, reduce myocardial contractility, or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC's effects on blood pressure, contractility, and impulse propagation. "><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.11"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.14"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.ddi.7"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.12"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117" text="&lt;main&gt;Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure, reduce myocardial contractility, or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC's effects on blood pressure, contractility, and impulse propagation. "><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.117.e.11"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.14"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.118.e.14"/></sentence><sentence biomedicalEntities="2" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119" lineNumber="163" text="In addition, with some drugs, beta blockade may precipitate increased withdrawal effects. " type="regular"><entity charOffset="18:28" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119.e.0" text="some drugs" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="with some drugs," preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="1488037"/></Normalization></entity><entity charOffset="30:43" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119.e.4" text="beta blockade" type="Drug_Class"><Normalization><mmtx cui="C3540676" phraseText="beta blockade" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="60:88" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119.e.5" text="increased withdrawal effects" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.120.e.0" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119.e.0"/><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.120.e.1" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119.e.0"/><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.120.e.2" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119.e.0"/><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119.e.4" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.119.e.5" type="Specific_Interaction"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.120" text="(See clonidine, guanfacine, and moxonidine below.) " type="negative"><entity charOffset="16:26" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.120.e.0" text="guanfacine" type="Biomedical_Entity"><Normalization><mmtx cui="C0079466" phraseText="guanfacine," preferredWord="Guanfacine" semType="phsu, orch"/><RxNorm RxCui="40114"/></Normalization></entity><entity charOffset="32:42" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.120.e.1" text="moxonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0066837" phraseText="moxonidine below." preferredWord="moxonidine" semType="phsu, orch"/><RxNorm RxCui="30257"/></Normalization></entity><entity charOffset="5:14" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.120.e.2" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="clonidine," preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.120.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.120.e.1"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.120.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.120.e.0"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.120.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.120.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122" lineNumber="165" text="&lt;item&gt;Digitalis glycosides: Concomitant administration of digoxin and BREVIBLOC leads to an approximate 10% to 20% increase of digoxin blood levels at some time points. " type="regular"><entity charOffset="115:126|135:147" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122.e.0" text="increase of blood levels" type="Increase_Interaction"/><entity charOffset="127:134" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="of digoxin blood levels" preferredWord="Digoxin" semType="strd, phsu, carb"/><mmtx cui="C0012265" phraseText="of digoxin blood levels" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="70:79" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122.e.3" text="BREVIBLOC" type="Drug"><Normalization><mmtx cui="C0591189" phraseText="BREVIBLOC" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="6:26" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122.e.4" text="Digitalis glycosides" type="Drug_Class"><Normalization><mmtx cui="C0012253" phraseText="&gt;Digitalis glycosides" preferredWord="Digitalis Glycosides" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122.e.2" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122.e.4"/><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122.e.0"><relations><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122.e.3" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122.e.2" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.122.e.0" type="Increase_Interaction"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.123" text="Digoxin does not affect BREVIBLOC pharmacokinetics. " type="negative"><entity charOffset="0:7" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.123.e.0" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="Digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="24:33" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.123.e.1" text="brevibloc" type="Biomedical_Entity"><Normalization><mmtx cui="C0591189" phraseText="BREVIBLOC pharmacokinetics." preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.123.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.123.e.1"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.124" text="Both digoxin and beta blockers slow atrioventricular conduction and decrease heart rate. " type="negative"><entity charOffset="17:30" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.124.e.0" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta blockers slow atrioventricular conduction" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="5:12" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.124.e.1" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="Both digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.124.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.124.e.0"/></sentence><sentence biomedicalEntities="0" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.125" lineNumber="165" text="Concomitant use increases the risk of bradycardia." type="irregular"><entity charOffset="38:49" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.125.e.0" text="bradycardia" type="Specific_Interaction"/><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.125.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.125.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.124" text="Both digoxin and beta blockers slow atrioventricular conduction and decrease heart rate. "><entity charOffset="17:30" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.124.e.1" text="beta blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta blockers slow atrioventricular conduction" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.124" text="Both digoxin and beta blockers slow atrioventricular conduction and decrease heart rate. "><entity charOffset="5:12" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.124.e.0" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="Both digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="4" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126" lineNumber="167" text="&lt;item&gt;Anticholinesterases: BREVIBLOC prolonged the duration of succinylcholine-induced neuromuscular blockade and moderately prolonged clinical duration and recovery index of mivacurium." type="regular"><entity charOffset="63:78" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.0" text="succinylcholine" type="Drug"><Normalization><mmtx cui="C0038627" phraseText="the duration of succinylcholine-induced neuromuscular blockade" preferredWord="Succinylcholine" semType="phsu, orch"/><mmtx cui="C0038627" phraseText="the duration of succinylcholine-induced neuromuscular blockade" preferredWord="Succinylcholine" semType="phsu, orch"/><RxNorm RxCui="3565"/></Normalization></entity><entity charOffset="175:185" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.1" text="mivacurium" type="Drug"><Normalization><mmtx cui="C0066621" phraseText="recovery index of mivacurium." preferredWord="mivacurium" semType="phsu, orch"/><RxNorm RxCui="30077"/></Normalization></entity><entity charOffset="6:25" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.2" text="Anticholinesterases" type="Drug_Class"><Normalization><mmtx cui="C0008425" phraseText="&gt;Anticholinesterases" preferredWord="Cholinesterase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1465414"/></Normalization></entity><entity charOffset="27:36" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.5" text="BREVIBLOC" type="Drug"><Normalization><mmtx cui="C0591189" phraseText="BREVIBLOC" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="37:62|87:109" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.6" text="prolonged the duration of neuromuscular blockade" type="Specific_Interaction"><Normalization><mmtx cui="C0700323" phraseText="the duration of succinylcholine-induced neuromuscular blockade" preferredWord="Observation of Neuromuscular Block" semType="dsyn"/></Normalization></entity><entity charOffset="125:152" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.8" text="prolonged clinical duration" type="Increase_Interaction"/><entity charOffset="125:134|157:171" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.10" text="prolonged recovery index" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.0" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.2"/><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.1" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.2"/><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.ddi.2"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.ddi.3"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.10"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.5" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.0" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.6" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.5" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.1" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.126.e.8" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="5" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127" lineNumber="169" text="&lt;item&gt;Antihypertensive agents clonidine, guanfacine, or moxonidine: Beta blockers also increase the risk of clonidine-, guanfacine-, or moxonidine-withdrawal rebound hypertension. " type="regular"><entity charOffset="6:29" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.0" text="Antihypertensive agents" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="&gt;Antihypertensive agents clonidine," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="30:39" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.1" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="&gt;Antihypertensive agents clonidine," preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="41:51" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.2" text="guanfacine" type="Drug"><Normalization><mmtx cui="C0079466" phraseText="guanfacine," preferredWord="Guanfacine" semType="phsu, orch"/><RxNorm RxCui="40114"/></Normalization></entity><entity charOffset="56:66" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.3" text="moxonidine" type="Drug"><Normalization><mmtx cui="C0066837" phraseText="moxonidine" preferredWord="moxonidine" semType="phsu, orch"/><RxNorm RxCui="30257"/></Normalization></entity><entity charOffset="68:81" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.7" text="Beta blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="Beta blockers also" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="158:178" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.8" text="rebound hypertension" type="Specific_Interaction"><Normalization><mmtx cui="C0520540" phraseText="moxonidine-withdrawal rebound hypertension." preferredWord="Rebound hypertension" semType="dsyn"/></Normalization></entity><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.1" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.0"/><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.2" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.0"/><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.3" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.0"/><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.7" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.8" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.7" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.8" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.3" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.7" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.8" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.2"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.3"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128" lineNumber="169" text="If, during concomitant use of a beta blocker, antihypertensive therapy needs to be interrupted or discontinued, discontinue the beta blocker first, and the discontinuation should be gradual." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127" Text="&lt;item&gt;Antihypertensive agents clonidine, guanfacine, or moxonidine: Beta blockers also increase the risk of clonidine-, guanfacine-, or moxonidine-withdrawal rebound hypertension. "/><anaphoraEntity charOffset="46:70" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.6" text="antihypertensive therapy" type="Expression"/><antecedentEntity charOffset="6:29" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.127.e.0" text="Antihypertensive agents" type="Drug_Class"/></anaphoraRelation><entity charOffset="112:123|141:146" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.0" text="discontinue first" type="Caution_Interaction"/><entity charOffset="156:189" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.2" text="discontinuation should be gradual" type="Caution_Interaction"/><entity charOffset="128:140" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.4" text="beta blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="the beta blocker first," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="46:70" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.5" text="antihypertensive therapy" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="antihypertensive therapy" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.ddi.2"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.5" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.4" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.128.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129" lineNumber="171" text="&lt;item&gt;Calcium channel antagonists: In patients with depressed myocardial function, use of BREVIBLOC with cardiodepressant calcium channel antagonists (e.g., verapamil) can lead to fatal cardiac arrests." type="regular"><anaphoraRelation><anaphoraEntity charOffset="105:149" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.6" text="cardiodepressant calcium channel antagonists" type="Expression"/><antecedentEntity charOffset="6-33" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.5" text="Calcium channel antagonists" type="Drug_Class"/></anaphoraRelation><entity charOffset="52:81" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.0" text="depressed myocardial function" type="SPAN"/><entity charOffset="90:99" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.1" text="BREVIBLOC" type="Drug"><Normalization><mmtx cui="C0591189" phraseText="use of BREVIBLOC" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="105:149" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.2" text="cardiodepressant calcium channel antagonists" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="with cardiodepressant calcium channel antagonists" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="157:166" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="6:33" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.5" text="Calcium channel antagonists" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="&gt;Calcium channel antagonists" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="186:201" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.8" text="cardiac arrests" type="Specific_Interaction"><Normalization><mmtx cui="C0018790" phraseText="lead to fatal cardiac arrests." preferredWord="Cardiac Arrest" semType="dsyn"/></Normalization></entity><entity charOffset="180:185" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.10" text="fatal" type="SPAN"/><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.3" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.2"/><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.8"><relations><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.1"/></relation><relation type="hasSeverity"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.0" ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.2" severity="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.10" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.129.e.8" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.130" lineNumber="173" text="&lt;item&gt;Sympathomimetic drugs: Sympathomimetic drugs having beta-adrenergic agonist activity will counteract effects of BREVIBLOC." type="regular"><entity charOffset="29:90" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.130.e.0" text="Sympathomimetic drugs having beta-adrenergic agonist activity" type="Drug_Class"><Normalization><mmtx cui="C0039052" phraseText="Sympathomimetic drugs" preferredWord="Sympathomimetics" semType="phsu"/><mmtx cui="C0001644" phraseText="beta-adrenergic agonist activity" preferredWord="Adrenergic beta-Agonists" semType="phsu"/><mmtx cui="C3536829" phraseText="beta-adrenergic agonist activity" preferredWord="beta-Adrenergic Agonist [EPC]" semType="phsu"/><RxNorm RxCui="10282"/></Normalization></entity><entity charOffset="118:127" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.130.e.1" text="BREVIBLOC" type="Drug"><Normalization><mmtx cui="C0591189" phraseText="effects of BREVIBLOC." preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="96:114" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.130.e.2" text="counteract effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.130.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.130.e.2"><relations><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.130.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.130.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.130.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.130.e.1" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.130.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="5" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131" lineNumber="175" text="&lt;item&gt;Vasoconstrictive and positive inotropic agents: Because of the risk of reducing cardiac contractility in presence of high systemic vascular resistance, do not use BREVIBLOC to control tachycardia in patients receiving drugs that are vasoconstrictive and have positive inotropic effects, such as epinephrine, norepinephrine, and dopamine." type="regular"><entity charOffset="301:312" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.0" text="epinephrine" type="Drug"><Normalization><mmtx cui="C0014563" phraseText="such as epinephrine," preferredWord="Epinephrine" semType="phsu, orch, horm, nsba"/><RxNorm RxCui="362"/></Normalization></entity><entity charOffset="314:328" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.1" text="norepinephrine" type="Drug"><Normalization><mmtx cui="C0028351" phraseText="norepinephrine," preferredWord="Norepinephrine" semType="phsu, orch, nsba"/><RxNorm RxCui="7508"/></Normalization></entity><entity charOffset="334:342" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.2" text="dopamine" type="Drug"><Normalization><mmtx cui="C0013030" phraseText="dopamine." preferredWord="Dopamine" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="224:291" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.3" text="drugs that are vasoconstrictive and have positive inotropic effects" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="169:178" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.7" text="BREVIBLOC" type="Drug"><Normalization><mmtx cui="C0591189" phraseText="BREVIBLOC to" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="190:201" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.8" text="tachycardia" type="SPAN"/><entity charOffset="77:156" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.9" text="reducing cardiac contractility in presence of high systemic vascular resistance" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.0" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.3"/><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.1" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.3"/><drugClassMembership drug="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.2" drugClass="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.3"/><drugInteraction id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.ddi.1"><interaction trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.7"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.8" ddi="true" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.7" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.3" trigger="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.131.e.9" type="Specific_Interaction"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.133" text="&lt;main&gt;BREVIBLOC (Esmolol Hydrochloride) is a beta adrenergic receptor blocker with a very short duration of action (elimination half-life is approximately 9 minutes). " type="negative"><entity charOffset="45:77" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.133.e.0" text="beta adrenergic blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C3536830" phraseText="a beta adrenergic receptor blocker with a very short duration of action" preferredWord="beta-Adrenergic Blocker [EPC]" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="6:15" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.133.e.1" text="brevibloc" type="Biomedical_Entity"><Normalization><mmtx cui="C0591189" phraseText="&gt;BREVIBLOC" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><entity charOffset="17:38" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.133.e.2" text="esmolol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0700606" phraseText="(Esmolol Hydrochloride" preferredWord="Esmolol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="49737"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.133.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.133.e.0"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.133.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.133.e.0"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.133.e.1" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.133.e.2"/></sentence><sentence id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.141" text="&lt;main&gt;All BREVIBLOC presentations are clear, colorless to light yellow, sterile, nonpyrogenic, iso-osmotic solutions of esmolol hydrochloride in sodium chloride. " type="negative"><entity charOffset="120:141" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.141.e.0" text="esmolol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0700606" phraseText="iso-osmotic solutions of esmolol hydrochloride" preferredWord="Esmolol hydrochloride" semType="phsu, orch"/><RxNorm RxCui="49737"/></Normalization></entity><entity charOffset="145:160" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.141.e.1" text="sodium chloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0037494" phraseText="in sodium chloride." preferredWord="Sodium Chloride" semType="bacs, inch, phsu"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="10:19" id="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.141.e.2" text="brevibloc" type="Biomedical_Entity"><Normalization><mmtx cui="C0591189" phraseText="All BREVIBLOC presentations" preferredWord="Brevibloc" semType="phsu, orch"/><RxNorm RxCui="151448"/></Normalization></entity><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.141.e.0" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.141.e.1"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.141.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.141.e.0"/><pair ddi="false" e1="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.141.e.2" e2="Dailymed.595cc3d5-1306-4828-aefa-5595219ffd62.s.141.e.1"/></sentence><positiveExamples number="28"/><negativeExamples number="47"/></document>